1. Deep-red fluorogenic probe for rapid detection of nitric oxide in Parkinson’s disease models
    Mingrui Weng et al, 2019, Sensors and Actuators B: Chemical CrossRef
  2. Dihydroquercetin improves rotenone‐induced Parkinsonism by regulating NF‐κB‐mediated inflammation pathway in rats
    Afolabi C. Akinmoladun et al, 2022, Journal of Biochemical and Molecular Toxicology CrossRef
  3. Nuclear factor‐kappa β as a therapeutic target for Alzheimer's disease
    Niraj Kumar Jha et al, 2019, Journal of Neurochemistry CrossRef
  4. mTORC1 pathway disruption abrogates the effects of the ciliary neurotrophic factor on energy balance and hypothalamic neuroinflammation
    Caroline André et al, 2018, Brain, Behavior, and Immunity CrossRef
  5. Rapamycin suppresses Aβ 25–35 - or LPS-induced neuronal inflammation via modulation of NF-κB signaling
    Ying-Chun Liu et al, 2017, Neuroscience CrossRef
  6. An Overview of Alzheimer’s Disease Pathogenesis and the Outlook for Its Treatment
    天佐 王, 2018, Advances in Clinical Medicine CrossRef
  7. Rapamycin Regulates Lipopolysaccharide-Induced Microglial Phagocytosis In Vitro
    S. J. Yang et al, 2024, Molecular Biology CrossRef
  8. Pharmacological interventions targeting nuclear factor-kappa B signaling in multiple sclerosis
    GerardJ. M. Martens et al, 2021, Neural Regeneration Research CrossRef
  9. A novel Nrf2 activator, RS9, attenuates secondary brain injury after intracerebral hemorrhage in sub-acute phase
    Tomoki Sugiyama et al, 2018, Brain Research CrossRef
  10. Sirolimus loaded chitosan functionalized poly (lactic-co-glycolic acid) (PLGA) nanoparticles for potential treatment of age-related macular degeneration
    Reshal Suri et al, 2021, International Journal of Biological Macromolecules CrossRef
  11. The role of dorsal root ganglia alpha-7 nicotinic acetylcholine receptor in complete Freund’s adjuvant-induced chronic inflammatory pain
    Xiaoyu Zhang et al, 2021, Inflammopharmacology CrossRef
  12. In silico-based Approach to Investigate the Ability of PEGylated Rapamycin to Inhibit Galectin-3
    Marwan Abdelmahmoud Abdelkarim Maki et al, 2021, Current Drug Discovery Technologies CrossRef
  13. Viral Induced Oxidative and Inflammatory Response in Alzheimer’s Disease Pathogenesis with Identification of Potential Drug Candidates: A Systematic Review using Systems Biology Approach
    Puneet Talwar et al, 2019, Current Neuropharmacology CrossRef
  14. Poly(ADP‐ribose) polymerase 1 induces cardiac fibrosis by mediating mammalian target of rapamycin activity
    Shuya Sun et al, 2019, Journal of Cellular Biochemistry CrossRef
  15. Rapamycin restores brain vasculature, metabolism, and blood-brain barrier in an inflammaging model
    Rheal A. Towner et al, 2021, GeroScience CrossRef
  16. Silymarin-albumin nanoplex: Preparation and its potential application as an antioxidant in nervous system in vitro and in vivo
    Mohammad Javad Sohrabi et al, 2019, International Journal of Pharmaceutics CrossRef
  17. mTOR inhibition as a possible pharmacological target in the management of systemic inflammatory response and associated neuroinflammation by lipopolysaccharide challenge in rats
    Demet Sinem Guden et al, 2021, Canadian Journal of Physiology and Pharmacology CrossRef
  18. All-trans retinoic acid reduces mammalian target of rapamycin via a Sirtuin1-dependent mechanism in neurons
    Yueting Guo et al, 2021, NeuroReport CrossRef
  19. The potential role of necroptosis in inflammaging and aging
    Gordon H. Royce et al, 2019, GeroScience CrossRef
  20. Differential compartmental processing and phosphorylation of pathogenic human tau and native mouse tau in the line 66 model of frontotemporal dementia
    Nora Lemke et al, 2020, Journal of Biological Chemistry CrossRef
  21. Inhibitor Kappa B Kinase β, Modulated by DJ-1/p-VHL, Reduces Phosphorylated Tau (p-Tau) Accumulation via Autophagy in Alzheimer’s Disease Model
    Wei-Ping Chen et al, 2021, Neuroscience CrossRef
  22. mTOR signaling and Alzheimer's disease: What we know and where we are?
    Samin Davoody et al, 2024, CNS Neuroscience & Therapeutics CrossRef
  23. Induction of autophagy protects human dental pulp cells from lipopolysaccharide‑induced pyroptotic cell death
    Yang Gao et al, 2020, Experimental and Therapeutic Medicine CrossRef
  24. The choroid plexus links innate immunity to CSF dysregulation in hydrocephalus
    Stephanie M. Robert et al, 2023, Cell CrossRef
  25. Cardamonin inhibits nitric oxide production modulated through NMDA receptor in LPS-Induced SH-SY5Y cell in vitro model
    Nur Khalisah Kaswan et al, 2020, Life Sciences, Medicine and Biomedicine CrossRef
  26. Protection by mTOR Inhibition on Zymosan-Induced Systemic Inflammatory Response and Oxidative/Nitrosative Stress: Contribution of mTOR/MEK1/ERK1/2/IKKβ/IκB-α/NF-κB Signalling Pathway
    Seyhan Sahan-Firat et al, 2018, Inflammation CrossRef